Effects of inhibition of PDE4 and TNF‐α on local and remote injuries following ischaemia and reperfusion injury
- 1 November 2001
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 134 (5) , 985-994
- https://doi.org/10.1038/sj.bjp.0704336
Abstract
The effects of phosphodiesterase (PDE)4 and TNF‐α inhibition were assessed on the local and remote injuries following intestinal ischaemia and reperfusion (I/R) injury in rats. The PDE4 inhibitor rolipram dose‐dependently (1 – 10 mg kg−1) suppressed the local (intestine) and remote (lung) increases in vascular permeability and neutrophil recruitment following mild I/R injury. SB207499 (ariflo), a structurally‐distinct PDE4 inhibitor, also suppressed the injuries following mild I/R injury. In a severe model of I/R injury, treatment with rolipram (10 mg kg−1) partially reversed the local and remote increases in vascular permeability, neutrophil recruitment, intestinal haemorrhage and intestinal LTB4 concentrations. The anti‐TNF‐α anti‐serum was more effective than rolipram at inhibiting local and remote injuries and prevented the lethality associated with severe I/R. Rolipram and anti‐TNF‐α prevented the increase in the concentrations of TNF‐α in the lung and intestine, but rolipram only partially inhibited the elevation of this cytokine in serum. Rolipram had little effect on the increases of IL‐1ß concentrations in lung and serum, whereas treatment with anti‐TNF‐α markedly increased the concentration of this cytokine. Concentrations of IL‐10 rose significantly in the lung and serum and these increases were blocked by rolipram or anti‐TNF‐α. The capacity of PDE4 inhibitors to block the recruitment of neutrophils into tissues, the production of LTB4 and of the pro‐inflammatory cytokines TNF‐α, IL‐1ß and IL‐6 appear to underlie their anti‐inflammatory effects in our model of I/R injury. Overall, PDE4 inhibition was less effective than inhibition of TNF‐α for protection against I/R injury. British Journal of Pharmacology (2001) 134, 985–994; doi:10.1038/sj.bjp.0704336Keywords
This publication has 42 references indexed in Scilit:
- ANTICYTOKINE THERAPIES FOR ACUTE INFLAMMATION AND THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME: IL-10 AND ISCHEMIA/REPERFUSION INJURY AS A NEW PARADIGMShock, 2000
- Differential inhibitory mechanism of cyclic AMP on TNF‐α and IL‐12 synthesis by macrophages exposed to microbial stimuliBritish Journal of Pharmacology, 1999
- Resident Cardiac Mast Cells Degranulate and Release Preformed TNF-α, Initiating the Cytokine Cascade in Experimental Canine Myocardial Ischemia/ReperfusionCirculation, 1998
- Splanchnic origin of cytokines in a porcine model of mesenteric ischemia-reperfusionSurgery, 1998
- Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?Trends in Pharmacological Sciences, 1997
- Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?Trends in Pharmacological Sciences, 1997
- PROTECTION BY PENTOXIFYLLINE AGAINST NORMOTHERMIC LIVER ISCHEMIA/REPERFUSION IN RATSTransplantation, 1995
- Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2.The Journal of Experimental Medicine, 1994
- Modulation of TNFα and IL-1β from endotoxin-stimulated monocytes by selective PDE isozyme inhibitorsInflammation Research, 1993
- Effect of a cyclic adenosine monophosphate phosphodiesterase inhibitor, DN-9693, on myocardial reperfusion injuryThe Annals of Thoracic Surgery, 1991